Click on a filter below to refine your search. Remove a filter to broaden your search.
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
The presence of Alzheimer’s disease pathology is related to Stages of Objective Memory Impairment in cognitively unimpaired older adults.
Less than one-quarter of older adults report they would want to take aducanumab (Aduhelm).
The findings were seen regardless of whether a person has normal, overweight or obese body mass index at baseline.
The risk for overactive bladder varies across individual cholinesterase inhibitor drugs.
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
But the biggest policy change — letting Medicare negotiate prices for prescription drugs — will not start to lower costs until 2025.
No significant association was seen for glaucoma surgery with dementia risk in a prospective study involving older adults.
New premium will be $170.10 a month, and the $21.60 boost is the biggest increase ever in dollar amount, but not in percentage terms